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Objectives. The aim of this study was to investigate the inter-
action between ischemic preconditioning (IP) and collateral re-
cruitment (CR) during ischemic adaptation in patients.
Background. The mechanism of ischemic adaptation still re-
mains controversial in humans.
Methods. The clinical, electrocardiographic, hemodynamic and
echocardiographic responses to three 150-s occlusions of the left
anterior descending coronary artery were assessed in relation to
CR in 18 patients with effort angina undergoing elective percuta-
neous transluminal coronary angioplasty.
Results. During the first occlusion, recruitable collateral circu-
lation (RCC) to the occluded myocardium was detected by myo-
cardial contrast echocardiography in 6 patients (Group C) and
was not seen in 12 (Group N). In Group N, all patients manifested
signs of severe ischemia during each inflation. However, their
symptoms and ST segment shift significantly decreased from the
first to the third occlusions, suggesting the occurrence of IP. The
elevation of mean pulmonary artery pressure and deterioration of
anterior wall motion were comparable between the first and the
third occlusions in Group N. In contrast, myocardial ischemia was
significantly less marked during occlusion in Group C than in
Group N, and no preconditioning effect was observed. The extent
of RCC did not differ between the first and the third occlusions in
each group.
Conclusions. Both IP and CR may play independent roles in
ischemic adaptation in humans. With RCC, myocardial ischemia
was greatly reduced. Without RCC, preconditioning clinically and
electrocardiographically lessened myocardial ischemia but failed
to preserve left ventricular function.
(J Am Coll Cardiol 1997;30:1679–86)
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Transient coronary artery occlusion during percutaneous
transluminal coronary angioplasty (PTCA) provides an excel-
lent human model of myocardial ischemia, and thus it has been
used for the investigation of ischemic preconditioning (IP) in
patients (1–5). Clinical, electrocardiographic (ECG) and he-
modynamic data have all revealed a decrease in the extent of
myocardial ischemia after the initial inflation (1,2), supporting
the occurrence of IP as proposed by experimental studies
(6–10). Deutsch et al. (1) reported that the second coronary
occlusion is characterized by less subjective anginal pain, less
ST segment shift, a lower mean pulmonary artery pressure and
less myocardial lactate production than with the first occlusion.
In contrast, other investigators (3–5) found no evidence that
myocardial protection against ischemia is induced by previous
coronary occlusion. Dupouy et al. (3) recently reported that
there was no difference in intracoronary ECGs, hemodynamic
changes and echocardiographic changes during the second or
third balloon inflations compared with the first. One possible
explanation for the discrepancies between these precondition-
ing studies in patients may be the variety of study protocols and
subjects as well as differences in the methods used to assess
collateral flow and in the duration of coronary occlusion. In
particular, the assessment of collateral flow seems likely to
have been inadequate in previous studies because most used
coronary angiography (CA) to visualize collateral circulation
(1–5) and did not investigate recruitable collateral circulation
(RCC) during coronary occlusion (1,3–5). CA only detects
collateral vessels with a diameter .100 mm (11) and thus is not
suitable for assessing the smaller collateral vessels in the
myocardium that play an important role in protection against
ischemia (12). Patients undergoing PTCA may have experi-
enced frequent episodes of myocardial ischemia in daily life,
and thus their collateral channels may open more easily than
those of experimental animals (13–16). Accordingly, assess-
ment of collateral recruitment (CR) during coronary occlusion
is important in human preconditioning studies. However, there
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have been no human studies that quantitated RCC in the
occluded microvascular bed in the myocardium at risk and
investigated the interdependence between IP and CR during
coronary occlusion.
Accordingly, we conducted the present study to investigate
1) how RCC develops in the occluded myocardium and
influences myocardial ischemia during repeated coronary oc-
clusion; and 2) whether IP is independent of CR in humans.
For the assessment of collateral circulation, we used myocar-
dial contrast echocardiography (MCE) in conjunction with
PTCA (17). MCE, using the intracoronary injection of micro-
bubbles of air, has been shown to be a promising method for
investigating the distribution of myocardial perfusion (17–27)
and is superior to CA for assessing collateral flow during
coronary occlusion (17,22,25,26).
Methods
The present investigation was approved by the ethics com-
mittee of the Osaka Police Hospital. Written informed consent
was obtained from all patients.
Patients. The study included 18 patients (14 men, 4 wom-
en; 41 to 76 years old, mean age 61) with normal or minimally
depressed normal left ventricular function who underwent
elective PTCA of the left anterior descending coronary artery.
Fourteen patients had single-vessel disease, and four had
two-vessel disease. Their baseline characteristics are shown in
Table 1. Patients with subtotal or total occlusion of the left
anterior descending coronary artery were excluded from the
study.
Study protocol. PTCA was performed through the femoral
approach. An 8F left guiding catheter (Sherpa SL4.0,
Medtronics Inc.) and a 5F right Judkins coronary arteriogra-
phy catheter (Niporica JR 50 2H, Nippo Corp., Osaka, Japan)
were advanced through sheaths placed in the femoral artery. A
7F pacing catheter (Lumelec, Cordis Corp.) was inserted into
the pulmonary artery. After heart rate, aortic pressure, and
pulmonary artery pressure were measured at baseline, right
and left coronary arteriograms were obtained using a 10-ml
injection of ioxaglate (Hexabrix-320, Tanabe Corporation,
Tokyo, Japan) before balloon inflation. Then the severity of
the coronary stenosis to be dilated was measured using digital
Abbreviations and Acronyms
CA 5 coronary angiography
CR 5 collateral recruitment
ECG 5 electrocardiogram, electrocardiographic
IP 5 ischemic preconditioning
MCE 5 myocardial contrast echocardiography (echocardiographic)
PTCA 5 percutaneous transluminal coronary angioplasty
RCC 5 recruitable collateral circulation
Table 1. Patient Characteristics
Pt No. Age (yr)/Gender
BP
(mm Hg)
mBP
(mm Hg)
PAP
(mm Hg)
mPAP
(mm Hg)
HR
(beats/min) WMS
Angio
Collat
Grade
Stenosis
(%) VD
Group N
1 74/F 118/72 98 24/10 17 79 0 1 72 2 (LAD, RCA)
2 41/M 126/76 94 20/10 15 70 0 0 57 1 (LAD)
3 45/M 130/90 110 16/7 11 83 1 0 50 1 (LAD)
4 58/M 120/80 100 23/12 17 68 0 0 53 1 (LAD)
5 76/M 114/52 72 20/8 15 52 1 0 62 1 (LAD)
6 64/F 112/70 90 26/13 22 88 1 1 49 1 (LAD)
7 60/M 82/68 75 22/13 17 94 0 0 69 2 (LAD, RCA)
8 63/M 160/82 114 18/8 13 107 0 2 76 1 (LAD)
9 74/M 130/74 94 28/14 19 72 0 0 79 1 (LAD)
10 53/M 126/76 96 30/16 23 69 0 0 72 1 (LAD)
11 68/M 138/64 92 19/8 13 78 0 0 61 2 (LAD, RCA)
12 55/M 150/94 128 27/9 16 76 0 0 51 1 (LAD)
Mean 61 126/75 97 23/11 17 78 63
SD 11 20/11 15 4/3 4 14 11
Group C
13 61/M 134/86 106 9/2 5 73 0 1 65 1 (LAD)
14 56/M 146/88 112 17/7 13 62 0 3 67 2 (LAD, LCx)
15 66/M 100/75 85 16/8 12 77 0 1 75 1 (LAD)
16 65/F 150/70 100 20/7 14 79 0 0 63 1 (LAD)
17 55/M 120/70 105 16/9 12 81 0 2 84 1 (LAD)
18 62/F 108/52 72 21/7 13 75 0 1 77 1 (LAD)
Mean 61 126/74 97 17/7* 12* 75 72
SD 5 20/13 15 4/2 3 7 8.2
*p , 0.05 versus Group N. Angio Collat 5 angiographic collateral; BP 5 blood pressure; HR 5 heart rate; F 5 female; LAD 5 left anterior descending coronary
artery; LCx 5 left circumflex coronary artery; M 5 male; mBP 5 mean blood pressure; mPAP 5 mean pulmonary artery pressure; PAP 5 pulmonary artery pressure;
Pt 5 patient; RCA 5 right coronary artery; Stenosis 5 severity of the coronary stenosis; VD 5 vessel disease; WMS 5 wall motion score.
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calipers, and angiographic coronary collateral vessel filling to
the left anterior descending coronary artery was graded using
a four-point scale (0 5 none; 3 5 good) (14). Baseline MCE
was then performed using 2 ml of sonicated ioxaglate contain-
ing microbubbles of air (mean size 10 mm), which was sepa-
rately injected into both the right and the left coronary arteries.
Ioxaglate was sonicated for 20 s at 20 kHz and 60 W using a
commercially available ultrasound homogenizer (Sonifier II,
model 250, Branson Corp.), as previously reported (17,18,24).
MCE images were acquired at or near the midpapillary muscle
short-axis level using a commercially available phased array
system (model SSH-160A ultrasound system, Toshiba Corp.,
Tokyo, Japan) with a 3.75-MHz transducer and recorded on a
videotape recorder (model BR-6400, Victor Corp., Yokohama,
Japan), from ;10 s before the injection of sonicated ioxaglate
until contrast enhancement was no longer evident at a constant
gain setting. After baseline CA and MCE were completed, the
balloon catheter was advanced across the lesion to be dilated.
Three 150-s balloon inflations were then performed at intervals
of 3 min. At 135 s of the first and third inflations, MCE of the
right coronary arterial injection of sonicated ioxaglate was
performed to assess recruitable myocardial perfusion within
the anterior segments. After these procedures, CA and MCE
with injection of nonsonicated and sonicated ioxaglate into
both the right and the left coronary arteries were performed. A
12-lead ECG was monitored during all procedures.
Medications. Long-acting nitrates, calcium channel antag-
onists or beta-adrenergic blocking agents were discontinued
$24 h before the study. A continuous infusion of intravenous
isosorbide dinitrate was started 1 h before the study at a
constant rate (10 to 15 mg/min). Intravenous heparin (200 IU/kg)
was administered before the first balloon inflation.
Assessment of collateral blood flow. The recorded MCE
images were analyzed off-line with a Hewlett-Packard Sonos
M2400A system. The video recordings were initially reviewed
to select cycles in which the left ventricle was optimally
visualized at the midpapillary short-axis level just before and
after contrast injection, and the end-diastolic frame of the
cycle showing the best delineation of the area with contrast
enhancement was selected for analysis. The area supplied by
collateral blood flow was determined by subtracting the area
with contrast enhancement after the right coronary artery
injection of sonicated ioxaglate at baseline or during balloon
inflations from that after completion of all three balloon
inflation procedures and then was expressed as a percentage of
the total myocardial area at the short-axis level (19,20,25) (Fig.
1). Our intraobserver and interobserver variations for measur-
ing the percent area supplied by collateral blood flow to the
total myocardial area were 8.7 6 4.4% and 9.1 6 5.2%,
respectively.
Assessment of myocardial ischemia. Anginal chest pain,
ST-T segment shift in the precordial leads of the 12-lead ECG,
hemodynamic changes and anterior wall motion were evalu-
ated before and at 120 s of the first and third inflations. Anginal
pain was assessed using a semiquantitative scale (0 5 no
anginal pain; 10 5 severe anginal chest pain) (1). ST segment
elevation was measured to the nearest 0.5 mm at 0.02 s after
the J point, and the maximal value in the precordial leads was
used for analysis. Anterior wall motion abnormality was graded
according to the following scale: 0 5 normokinesia; 1 5 mild
hypokinesia; 2 5 hypokinesia; 3 5 severe hypokinesia; 4 5
akinesia or dyskinesia. ST segment elevation and wall motion
abnormality were evaluated in blinded manner by two observ-
ers (F.I., A.S.) who viewed the ECGs or echocardiograms in
random order and without knowledge of which patient was
being presented. Differences in interpretation were resolved by
consensus.
Statistical analysis. Results are expressed as mean value 6
SD. Hemodynamic variables, collateral flow and indexes of
Figure 1. Two-dimensional echocardiographic short-axis view at the
midpapillary level after injection of sonicated ioxaglate during balloon
inflation (top) and after all angioplasty procedures (bottom). To
quantitate the area supplied by collateral flow (ASC), the total
myocardial area (TMA) and the area enhanced by contrast injection
(AE) were digitized using a cursor controlled with a joystick. The
area supplied by collateral flow was expressed as a percentage of the
total myocardium using the following equation: ASC 5 (AEinflation/
TMAinflation 2 AEcontrol/TMAcontrol) 3 100.
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myocardial ischemia were compared between groups of pa-
tients with and without collateral flow and between the first
and third inflations in each group using the unpaired and
paired Student t test, Mann-Whitney U test and Wilcoxon
single rank test. When serial changes in collateral flow and the
indexes of myocardial ischemia were compared between the
two groups, repeated measures analysis of variance was used,
followed by the Scheffe´ F test. This analysis was performed on
an Apple Macintosh computer using Statview IV software
(Abacus Concepts). A p value ,0.05 was accepted as indicat-
ing statistical significance.
Results
Clinical characteristics (Table 1). During the first infla-
tion, collateral blood flow was demonstrated in six patients
(Group C) but not in 12 patients (Group N). There were no
differences between groups with respect to age, gender, sys-
temic blood pressure, mean blood pressure, heart rate and
baseline wall motion score. There was a significant difference
between the groups with respect to pulmonary artery pressure
(p , 0.05). There was a moderate difference between the
severity of the coronary stenosis to be dilated, although it was
not statistically significant (p 5 0.08).
Table 2. Change in Area Supplied by Collateral Flow
Pt No. Baseline (%)
Inflation (%)
1st 3rd
Group N
1 0 0 0
2 0 0 0
3 0 0 0
4 0.22 0.12 0.11
5 0.31 0 0.30
6 0 0 0.30
7 0.37 0.39 0.50
8 0 0 1.16
9 0 1.50 1.40
10 1.40 1.10 1.50
11 0 0 2.84
12 0 2.60 3.00
Mean 0.2 0.5 0.9
SD 0.4 0.8 1.1
Group C
13 1.82 13.26 10.74
14 4.68 12.94 13.97
15 0 12.41 17.90
16 0 20.03 17.93
17 2.88 18.12 18.87
18 12.17 14.37 23.43
Mean 3.6* 15.2† 17.1†
SD 4.6 3.1 4.4
*p , 0.05, †p , 0.001 versus Group N. Pt 5 patient.
Table 3. Anginal Score, ST Segment Shift and Wall Motion Score
Pt No.
Anginal Score ST Segment Shift (mV) Wall Motion Score
BL Inf 1 Inf 3 BL Inf 1 Inf 3 BL Inf 1 Inf 3
Group N
1 0 6 3 0 0.3 0.2 0 4 4
2 0 10 6 0 0.6 0.3 0 4 4
3 0 3 3 0 0.8 0.8 1 4 4
4 0 10 6 0 0.3 0.2 0 4 4
5 0 1 2 0 0.5 0.2 1 4 4
6 0 3 1 0 0.15 0.05 1 4 4
7 0 10 10 0 0.2 0.1 0 4 4
8 0 6 3 0 0.1 0.15 0 4 4
9 0 0 0 0 0.2 0.15 0 4 4
10 0 10 5 0 0.5 0.4 0 4 4
11 0 0 0 0 0.6 0.2 0 4 4
12 0 10 8 0 0.55 0.5 0 4 4
Mean 0 5.7 3.9* 0 0.40 0.27† 0.25 4 4
SD 0 4.3 3.1 0 0.22 0.21 0.45 0 0
Group C
13 0 0 0 0 0.1 0.1 0 1 2
14 0 0 0 0 0.05 0.05 0 1 1
15 0 0 0 0 0 0 0 1 1
16 0 0 0 0 0 0 0 0 0
17 0 0 0 0 0 0 0 1 1
18 0 4 0 0 0.1 0 0 4 1
Mean 0 0.67‡ 0§ 0 0.04§ 0.03‡ 0 1.3§ 1§
SD 0 1.63 0 0 0.05 0.04 0 1.4 0.63
*p , 0.05, †p , 0.01 versus inflation 1. ‡p , 0.05, §p , 0.01 versus Group N. BL 5 baseline; Inf 5 inflation; Pt 5 patient.
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Collateral blood flow during repeated coronary occlusion.
In Group N, the area supplied by collateral flow at baseline
and at the first and third inflations was, respectively, 0.2 6
0.4%, 0.5 6 0.8% and 0.9 6 1.1% of the left ventricle. In
Group C, the area supplied by collateral flow at baseline and at
the first and third inflations was, respectively, 3.6 6 4.6%,
15.2 6 3.1% and 17.1 6 4.4% of the left ventricle. There was
a significant difference in the serial change of collateral flow
between Groups N and C (p , 0.0001). There was a significant
difference between Groups N and C in the area supplied by
collateral flow at baseline (p , 0.05), the first inflation (p ,
0.001) and the third inflation (p , 0.001) (Table 2). The area
supplied by collateral flow did not differ between the first and
third inflations in both Groups N and C.
Symptoms during repeated coronary occlusion. The serial
change in anginal symptoms was significantly different between
Groups N and C (p , 0.01). Before each inflation, all patients
had no symptoms. In Group N, 10 of 12 patients developed
anginal symptoms during the first inflation. The symptom score
decreased in seven patients, increased in one and did not
change in two at the third inflation. Overall, the third inflation
was characterized by less severe anginal symptoms than the
first inflation in Group N (p , 0.05). In contrast, only one
patient in Group C (Patient 18) had anginal symptoms (anginal
pain scale: 4) during the first inflation, which disappeared by
the third inflation. There were significant differences between
Groups N and C in the anginal symptoms noted during the first
and third inflations (p , 0.05 and p , 0.01, respectively)
(Table 3).
ECG changes during repeated coronary occlusion. There
was a significant difference in the serial changes of ST-T wave
shifts between Groups N and C (p , 0.01). Before each
inflation, there was no ST-T segment shift in the precordial
ECG leads in any patient. In Group N, all patients showed
significant ST-T segment shift (0.40 6 0.22 and 0.27 6 0.21 mV
at the first and third inflations, respectively). The magnitude of
the ST-T segment shift was significantly less during the first
inflation than during the third inflation in Group N (p , 0.01).
In contrast, all patients in Group C showed only slight ECG
changes. The ST-T segment shift was significantly smaller in
Group C than in Group N during the first and third inflations
(p , 0.01 and p , 0.05, respectively) (Table 3).
Echocardiographic changes during repeated coronary oc-
clusion. Changes in the anterior wall motion score at baseline
and during the first and third inflations are shown in Table 3.
Serial changes in the anterior wall motion score differed
significantly between Groups N and C (p , 0.0001). At
baseline, normokinesia (grade 0) was seen in nine Group N
patients and in all Group C patients. Three patients from
Group N showed slight deterioration of wall motion (grade 1).
During each inflation, anterior wall motion severely deterio-
rated and manifested akinesia (grade 4) in all Group N
patients. In contrast, no akinesia was observed in Group C,
except in Patient 15 during the first inflation. There were
significant differences in wall motion score between Groups N
and C during the first and third inflations (p , 0.001 and p ,
0.001, respectively).
Hemodynamic variables during repeated coronary occlu-
sion. Table 4 shows the hemodynamic responses to repeated
coronary occlusions in Groups N and C. In both groups, mean
blood pressure and heart rate did not change significantly with
repeated coronary occlusion. Mean pulmonary artery pressure
increased significantly during the first and third coronary
occlusions in Group N (p , 0.05 and p , 0.01, respectively),
whereas there was no change in Group C. Between the first
and third inflations, there were no significant changes in mean
pulmonary artery pressure at baseline and during inflation in
each group, but there was a significant difference between
Groups N and C in mean pressure during the first and third
inflations (p , 0.01 and p , 0.001, respectively) as well as at
baseline, before the first and third inflations (p , 0.05 and p ,
0.01, respectively).
Discussion
Different responses to repeated coronary occlusion in pa-
tients with and without RCC. Since Murry et al. (6,7) reported
that an antecedent ischemic episode delayed irreversible cel-
lular injury after coronary occlusion, several studies have been
conducted, and the concept of IP has been established by
experimental data excluding animals with high collateral flow.
However, to our knowledge, IP has never been investigated
independently of CR in humans because of the difficulty in
assessing collateral blood flow in the occluded microvascular
Table 4. Hemodynamic Changes During Repeated Coronary Occlusion
mBP (mm Hg) HR (beats/min) mPAP (mm Hg)
BL Occl BL Occl BL Occl
Group N
Inf 1 94.4 6 17.2 90.0 6 15.6 73.1 6 12.8 73.7 6 13.7 16.4 6 3.4* 23.7 6 6.5†‡
Inf 3 91.1 6 14.5 87.4 6 12.1 71.7 6 15.0 71.1 6 15.3 19.2 6 6.1‡ 24.0 6 5.4‡\
Group C
Inf 1 96.7 6 15.1 94.7 6 13.1 74.5 6 6.7 79.1 6 4.3 11.5 6 3.3 12.0 6 3.3
Inf 3 93.5 6 14.2 95.0 6 12.3 78.8 6 4.4 80.3 6 4.5 10.0 6 2.6 11.7 6 2.8
*p , 0.05, ‡p , 0.01, §p , 0.001 versus Group C. †p , 0.05, \p , 0.01 versus baseline. Data presented are mean
value 6 SD. Occl 5 during inflation; other abbreviations as in Tables 1 and 3.
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bed. Because previous preconditioning studies (1–5) enrolled
patients both with and without RCC or did not completely
exclude CR, they could not investigate acquisition of ischemic
tolerance in relation to CR. However, in the present study we
assessed RCC in the myocardium at risk after coronary
occlusion, using MCE in conjunction with PTCA, and could
distinguish between patients with and without RCC. Our
results showed that the response to repeated ischemic episodes
was different in patients with and without RCC. In patients
with RCC that was not enhanced by repeated coronary occlu-
sion, myocardial ischemia was far less severe during coronary
occlusion. In contrast, all patients without RCC had severe
ischemia during each balloon inflation, but the third occlusion
was characterized by less clinical and ECG evidence of myo-
cardial ischemia than during the first occlusion, suggesting the
acquisition of ischemic tolerance during repeated coronary
occlusion. This observation in patients without RCC seems to
be the first evidence that ischemic tolerance can be acquired
independently of CR in humans because previous studies that
showed a clinical preconditioning effect could not completely
exclude the involvement of CR (1) or otherwise concluded that
the acquisition of ischemic tolerance in the clinical setting was
attributable to enhanced collateral circulation (2).
Acquisition of myocardial ischemic tolerance independent
of CR. In the present study, acquisition of ischemic tolerance
in humans was demonstrated by excluding the data from
patients with recruitable collateral flow. Anginal symptoms and
ST-T segment shift were less marked at the third inflation than
the first in patients without RCC (Group N), supporting the
concept of IP in humans, as has been shown in animal
experiments (6–10). However, in addition to the lesser clinical
and ECG evidence of myocardial ischemia, we also showed
that previous coronary occlusions had no effect on preserving
left ventricular function at the next occlusion. The extent of the
elevation in mean pulmonary artery pressure and deterioration
in anterior wall motion during the third inflation were compa-
rable to those during the first inflation in Group N, whereas
heart rate and mean aortic pressure did not differ both before
and during each inflation. Because clinical symptoms and ECG
changes generally appear in the later stage of myocardial
ischemia after coronary occlusion compared with hemody-
namic changes and regional wall motion abnormality (28),
repeated coronary occlusion might have preconditioned the
myocardium to raise the threshold for provoking myocardial
ischemia.
Deutsch et al. (1) also suggested that repeated coronary
occlusion induced IP, probably in the absence of collateral
enhancement in the clinical setting. They concluded that no
increase in collateral blood flow was induced by repeated
coronary occlusion because coronary venous blood flow de-
creased during the second occlusion. Their data are consistent
with ours but do not rule out the possibility that RCC appeared
during the second occlusion in some of their patients.
Dupouy et al. (3) investigated IP in patients without severe
coronary stenosis in whom RCC was considered to be insig-
nificant. They concluded that brief episodes of ischemia did
not induce IP, as evidenced by changes in intracoronary ECG
and echocardiographic and hemodynamic variables in patients
with no angiographic evidence of collateral circulation before
coronary occlusion. Thus, their conclusions seemed different
from ours. However, the difference between their findings and
ours may be explained by the power of their study to find
differences because of the limited number of patients. In fact,
they found a nonsignificant but moderate decrease in ST
segment elevation from the first to the third inflation (from
1.8 6 1.2 to 1.35 6 0.9 mV). Additionally, the duration of
coronary occlusion was slightly longer in our study than in their
study (150 vs. 120 s), which is another possible explanation.
The present study seemed to shed further light on the question
of whether IP occurs in patients and, if so, under what
conditions. We clearly determined the presence or absence of
RCC during each coronary occlusion in individual subjects,
which, to our knowledge, has not been assessed in previous
studies.
Recruitment of collateral flow and myocardial ischemia.
Another goal of the present study was to investigate whether
an increase in RCC in the occluded myocardium was induced
by repeated coronary occlusion and how it influenced myocar-
dial ischemia. MCE demonstrated RCC in six of our patients
(Group C). The percent area supplied by recruitable collateral
flow did not differ between the first and third inflations, so the
presence or absence of CR seemed to be determined before
the first coronary occlusion. In Group C, coronary stenosis was
more severe, and the area supplied by collateral flow at
baseline was larger than that in Group N, suggesting that the
presence of “preexisting collateral channels” that are ready to
open might be related to the immediate appearance of RCC.
Cribier et al. (2) also described the striking development of
collateral circulation during the first coronary occlusion com-
pared with baseline CA, which agrees with our findings.
However, unlike in their study, we did not observe enhance-
ment of RCC with repeated coronary occlusion. This discrep-
ancy may be explained by the different methods used for
assessment of collateral circulation. Cribier et al. used CA to
assess collateral circulation, which reflects epicardial collateral
vessel filling but does not necessarily reflect myocardial perfu-
sion in the occluded bed (18,22,25,26), especially immediately
after coronary occlusion (17).
The magnitude of myocardial ischemia during each infla-
tion in patients with RCC was significantly lower than that in
patients without RCC. Except during the first inflation in
Patient 15 (Table 1), no significant myocardial ischemia was
seen with each inflation in patients with RCC. RCC eliminated
the clinical, ECG, hemodynamic and echocardiographic evi-
dence of myocardial ischemia from the time of the initial
inflation. This observation in patients with RCC was in marked
contrast to the preconditioning effect in patients without RCC,
which only lessened the clinical and ECG features of myocar-
dial ischemia after the initial inflation but not the hemody-
namic and echocardiographic variables. Thus, the mechanisms
underlying ischemic adaptation during repeated coronary oc-
clusion appear to be different between IP and CR. The
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mechanism of ischemic adaptation by CR is probably due to
restoration of a sufficient oxygen supply to the ischemic
myocardium to meet oxygen demand, whereas that due to IP is
probably not and may be due to improved ischemic tolerance
of cardiac myocytes (6–10).
Mechanism of IP. Our findings do not provide enough
evidence to elucidate the mechanism of IP. Murry et al. (6)
suggested that preconditioning by intermittent reperfusion due
to washout of the catabolites that accumulate during ischemia
might play a role in decreasing the extent of ischemia with
subsequent balloon inflations. Other mechanisms, such as
endogenous adenosine, have been reported in previous studies
(8–10). Because adenosine may contribute to the recruitment
of collateral circulation as well as making the myocardium
more resistant to ischemic insults, endogenous adenosine may
have contributed to the cardioprotective effect seen in the
present study. We previously reported (29) that myocardial
oxygen consumption was reduced in the second supine ergo-
metric exercise test performed in patients with effort angina
compared with that during the first exercise test. In that study,
adenosine release was greater during the second exercise
session than during the first. Although supply-type and
demand-type ischemia may be different, reduced myocardial
oxygen demand and enhanced adenosine release might have
ameliorated myocardial ischemia during the subsequent bal-
loon inflation in the present study.
The baseline differences between the two groups may at
least partially explain the mechanism of ischemic adaptation.
That the group with RCC had both moderately worse baseline
coronary stenosis of the dilated vessel and significantly less
elevated baseline pulmonary artery pressures, coupled with the
observation that this group had significantly less marked
myocardial ischemia during coronary occlusions, might mean
that the group with RCC had already undergone IP through
repeated episodes of angina, and, therefore, no additional IP
occurs during coronary occlusions performed in the present
study.
Limitations of the study. The present study had the follow-
ing limitations: 1) For ethical reasons, intravenous administra-
tion of nitroglycerin was continued throughout the study in all
patients. Nitroglycerin is reported to affect collateral circula-
tion in dogs (30). However, the infusion was maintained at a
constant rate throughout the study and thus probably had little
influence on the results. 2) We only assessed collateral perfu-
sion through the right coronary artery and did not assess
recruitable collateral flow from the left coronary artery. How-
ever, it seems unlikely that assessment of left coronary artery
collateral flow would greatly affect the results because a) it is
remarkable how the two groups of patients are differentiated,
even without the data of left to left collateral flow; and b) there
was little discrepancy between the cardioprotective effect dur-
ing coronary occlusion and the presence of collateral perfusion
through the right coronary artery in the previous report (17).
Clinical implications. Although great attention has been
focused on the phenomenon of IP, few data are available in the
clinical setting. We first showed that IP is independent of CR
in humans, which has previously been shown only in animal
studies. These findings may help in understanding the discrep-
ancies between clinical and experimental data as well as the
mechanism of ischemic adaptation in patients with coronary
artery disease.
We gratefully acknowledge the expert technical assistance of the staff of the
catheterization laboratory of Osaka Police Hospital.
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